Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α
- Angew Chem Int Ed Engl. 2012 Nov 12;51(46):11463-7. doi: 10.1002/anie.201206231.
- 1. Department of Chemistry, Yale University, New Haven, CT 06511, USA.
E3 ubiquitin ligases, such as the therapeutically relevant VHL, are challenging targets for traditional medicinal chemistry, as their modulation requires targeting protein-protein interactions. We report novel small-molecule inhibitors of the interaction between VHL and its molecular target HIF1α, a transcription factor involved in oxygen sensing.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: E1/E2/E3 EnzymeResearch Areas: Others